X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CSTL

Closed

Castle Biosciences Inc

20.34
-0.08 (-0.39%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 20.42
Day's Range: 20.0101 - 20.58
Send
When Written:
 
22.72
Castle Biosciences Inc. is a commercial-stage dermatological cancer company that develops and markets diagnostic and prognostic tests for skin cancers. The company was founded in 2007 and is headquartered in Friendswood, Texas, USA.

Castle Biosciences specializes in developing and commercializing diagnostic tests for melanoma, a type of skin cancer that can be deadly if not detected and treated early. The company's flagship product is the DecisionDx-Melanoma test, which provides a personalized risk assessment for patients with melanoma based on the genetic profile of their tumor. The test helps doctors determine the likelihood of the cancer spreading and the appropriate course of treatment.

In addition to melanoma, Castle Biosciences also offers diagnostic tests for other skin cancers, including DecisionDx-SCC for squamous cell carcinoma and DecisionDx-UM for uveal melanoma. The company's tests are used by dermatologists, oncologists, and other healthcare providers in the United States and internationally.

Castle Biosciences is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol CSTL. The company has received numerous awards and recognitions for its innovative diagnostic technologies and commitment to improving patient outcomes in skin cancer.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X